Capricor Therapeutics is a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment of rare diseases. Founded in 2005, Capricor is dedicated to advancing innovative regenerative medicine solutions to address unmet medical needs. With a strong emphasis on research and development, Capricor Therapeutics is committed to improving patient outcomes and making a meaningful impact in the field of healthcare.

capricor-therapeutics

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div>The Medical Science Liaison (MSL) Director is a field-based scientific leader responsible for delivering Capricor's scientific engagement strategy across an assigned territory of national and regional KOLs treating Duchenne muscular dystrophy (DMD) and DMD cardiomyopathy. The role focuses on scientific exchange with thought leaders, treatment centers, and academic institutions in neuromuscular disease, cardiology, and pediatric specialty care; identification of clinical and research opportunities; and translation of field insights into Capricor's medical strategy for Deramiocel. This individual partners closely with the Medical Director, VP Medical Affairs, HEOR / RWE, Pharmacovigilance, Clinical Development, and the broader U.S. MSL team.</div>

Regional Director, Medical Science Liaison (US West)

Regional Director, Medical Science Liaison (US East)

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div><span data-contrast="auto">The National Account Director will own payer access and coverage strategy for assigned national and regional commercial payers, PBMs, Medicaid plans, Medicare, and integrated delivery networks. This is a field-based role responsible for securing&nbsp;appropriate coverage&nbsp;and&nbsp;reimbursement for&nbsp;Deramiocel,&nbsp;Capricor's&nbsp;lead cell therapy for Duchenne muscular dystrophy. This individual will partner closely with Market Access leadership, Trade &amp; Patient Services, Medical Affairs, HEOR, Sales, and Patient Advocacy to translate the&nbsp;Deramiocel&nbsp;value proposition into coverage decisions, medical policy positions that support timely, equitable patient access in a high-cost, rare-disease, medical-benefit market. The position will engage senior payer decision-makers, deliver compelling clinical and economic value stories, navigate medical-benefit dynamics unique to infused cell therapies, and feed payer intelligence back into&nbsp;Capricor's&nbsp;launch and&nbsp;access&nbsp;strategy.</span><span data-ccp-props="{}">&nbsp;</span></div>

National Account Director

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div><span data-contrast="auto">Essential functions of the Director / Senior Director will include engagement and alignment with key internal company stakeholders and external vendors, with an emphasis on ensuring seamless patient access of Capricor’s approved therapies. The Director / Senior Director will be accountable for building a strategic partner team, responsible for ensuring timely site of care activation and operational readiness. The field-team will deliver key Capricor Patient access and reimbursement offerings and ensure execution of all patient referrals and product distribution, with the objective of adding to the provider / patient brand experience.</span><span data-ccp-props="{}">&nbsp;</span></div>
<div>
<div>
<p><span data-contrast="auto">It is critical that the person has past Commercial rare disease launch,&nbsp;Patient Services, and specialty infused drug distribution experience, and can identify and drive innovative initiatives around US Market / patient access strategy, patient referral and adherence management, patient affordability,&nbsp;operational&nbsp;process and programs, and patient / caregiver customer engagement models.</span><span data-ccp-props="{}">&nbsp;</span></p>
</div>
<div>
<p><span data-contrast="auto">The position is a field-based position, and will&nbsp;partner closely&nbsp;with Patient Services, Trade &amp; Distribution,&nbsp;Medical Affairs,&nbsp;Sales, Sales Operations, Marketing, Patient Advocacy, Legal and Compliance teams&nbsp;to identify and remove&nbsp;patient access&nbsp;barriers, and&nbsp;enhance the overall patient and provider&nbsp;treatment experience.</span><span data-ccp-props="{}">&nbsp;</span></p>
</div>
</div>

Director / Senior Director, Head of Patient Access & Reimbursement

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div><span data-contrast="auto">As Associate Director / Director of HCP Marketing at Capricor, you will lead the development and execution of the healthcare professional marketing strategy for deramiocel, Capricor’s first commercial product, a cell therapy for Duchenne muscular dystrophy (DMD). In this role, you will translate clinical evidence, market insights, and competitive intelligence into differentiated messaging and a multi-channel education and promotional campaign that drives awareness, adoption, and appropriate use among neuromuscular specialists and the broader DMD care team. You will own brand planning and execution for the HCP audience, manage agency and vendor partners, and serve as a key cross-functional partner across the commercial organization. The ideal candidate brings deep biopharmaceutical brand marketing expertise, a builder mindset suited to a first-launch environment, and a genuine commitment to serving the rare disease community.</span><span data-ccp-props="{&quot;335559739&quot;:120}">&nbsp;</span></div>

Associate Director, HCP Marketing

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div>We are seeking a Network Engineer to support and scale network infrastructure within a fast-paced biotech environment. This role will be responsible for designing, implementing, and maintaining secure, compliant, and highly available network systems that support research labs, clinical systems, and corporate operations.</div>
<div><br>The ideal candidate has strong enterprise networking experience and understands the unique requirements of GMP-regulated environments, including system validation, data integrity, and audit readiness.</div>

Network Engineer

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<strong>Deramiocel&nbsp;</strong>(<em>CAP-1002</em>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div>
<div>We are looking for an exceptional individual to join our growing team as a Material Handler. The Material Handler will play a critical role in supporting our manufacturing and logistics operations by managing inventory, processing shipments, and ensuring the efficient movement of materials within our facilities. This role requires attention to detail, a commitment to quality, and the ability to work effectively in a fast-paced environment.</div>
<div>&nbsp;</div>
<div>Operations run between <strong>6:00 AM–6:00 PM</strong>, with roles assigned to one of two set shift windows: <strong>6:00 AM–2:30 PM</strong> or <strong>9:30 AM–6:00 PM</strong>. Openings are distributed across locked weekly schedules—<strong>Sat–Wed, Tue–Sat, Thu–Mon, and Fri–Tue</strong>—and you will be hired into one of these specific schedules. While shifts do not rotate, candidates should maintain flexibility for <strong>1–2 hours of overtime as needed</strong> to support production and shipping demands.</div>
</div>

Materials Handler

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<b>Deramiocel&nbsp;</b>(<i>CAP-1002</i>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div>

Quality Compliance Associate I/II

Manufacturing Associate I

<div>Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is&nbsp;<b>Deramiocel&nbsp;</b>(<i>CAP-1002</i>), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.</div><div><br></div><div>
<p style="text-align: justify; margin: 0in; font-size: 11pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'Times New Roman', serif;">Capricor is seeking a self-motivated team player with attention to detail, who enjoys organizing, making processes better, and making a difference in patient lives.&nbsp; </span><span style="font-family: 'Times New Roman', serif;">The Quality Assurance QA Associate II – Quality Events Team (QET) is responsible for cross-functional triage of issues and managing, investigating, and resolving deviations, non-conformances, and corrective and preventive actions (CAPAs) in compliance with cGMP, SOPs, and regulatory requirements. This role ensures the consistent application of quality standards across manufacturing, laboratory, and clinical operations while supporting continuous improvement initiatives.</span></p>
<p style="margin: 0in -1.5pt 0in 0in; text-align: justify; font-size: 11pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<span style="font-size: 11.0pt; font-family: 'Times New Roman', serif;">The position will be hybrid, Thursday-Monday, 8am-5pm. &nbsp;&nbsp;</span></div>

Get a job referral to Capricor Therapeutics

Description

Jobs· 10 open

About

Financials

Referrals